Sisätautien yksikkö
Department of Internal Medicine

Julkaisut 2004
Publications 2004

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Farge D et al. Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry.
2 Snowden JA et al. Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR .
3 Andrulionyte L et al. Common polymorphisms of the PPAR-gamma2 (Pro12Ala) and PGC-1alpha (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial.
4 Autio K et al. Starch in food diabetes and coronary heart disease.
5 Barnett AH et al. Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabtes and nephropathy.
6 Boden G, Laakso M. Lipids and glucose in type 2 diabetes: what is the cause and effect?
7 Charbonnel B et al. The prospective pioglitazone clinical trial in macrovascular events (PROactive): can pioglitazone reduce cardiovascular events in diabetes? Study design and baseline characteristics of 5238 patients.
8 Chiasson J-L et al. Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data.
9 Cuesta-Munoz AL et al. Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutation.
10 D'Agostino Jr RB et al. Cardiovascular disease risk factors predict the development of type 2 diabetes. The Insulin resistance atherosclerosis study.
11 Girman CJ et al. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).
12 Gylling H et al. Polymorphisms in the ABCG5 and ABCG8 genes associate with cholesterol absorbtion and insulin sensitivity.
13 Hakala T et al. Cardioplegic arrest does not increase the risk of atrial fibrillation after coronary artery bypass surgery.
14 Hannonen P, Mikkelsson M. M79.0 - mistä fibromyalgiassa on kyse, mitä hoidoksi?
15 Hartikainen J. Sepelvaltimoiden pallolaajennushoito.
16 Hedman A et al. Inducibility of life-threatening ventricular arrhythmias is related to maximum left ventricular thickness and clinical markers of sudden cardiac death in patients with hypertrophic cardiomyopathy attridutable to the Asp175Asn mutation in the Alfa-tropomyo.
17 Heikkinen A-M et al. Leucine7 to proline7 polymorphism in prepro-NPY gene and femoral neck bone mineral density in postmenopausal women .
18 Heikkinen S. Glucose Metabolism in Heterozygous Hexokinase II Knock-out Mice.
19 Heinonen S et al. The 121Q allele of the plasma cell membrane glycoprotein 1 gene predisposes to polycystic ovary syndrome.
20 Hills SA et al. The EGIR-RISC Study (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives.
21 Hirvonen EA et al. Thyroid storm prior to induction of anaesthesia.
22 Husman TM, Luosujärvi RA. Reply to letter by Lange .
23 Häkkinen A et al. A home-based two-year strenght training period in early rheumatoid arthritis led to good long-term compliance: a five-year followup.
24 Häkkinen A et al. Sustained maintenance of exercise induced muscle strength gains and normal bone mineral density in patients with early rheumatoid arthritis: a 5 year follow up .
25 Jantunen E, DŽAmore F. Stem cell transplantation for peripheral T-cell lymphomas .
26 Jantunen E et al. Primaarit luulymfoomat. KYS:n kokemukset 1990-2003.
27 Jantunen E et al. Candidaemia in allogeneic stem cell transplant recipients: low risk without fluconazole prophylaxis.
28 Jantunen E et al. Invasive fungal infections in autologous stem cell transplant recipients: a nation-wide study of 1188 transplanted patients.
29 Jantunen E et al. Autologous stem cell transplantation in patients with primary amyloidosis: a nation-wide survey.
30 Jantunen E et al. Autologous stem cell transplantation in adult patients with peripheral T-cell lymphoma: a nation-wide survey.
31 Jokinen JJ et al. Effects of coronary artery bypass related conduction defects: a 10-year follow-up study.
32 Juutilainen A et al. Gender difference in the impact of type 2 diabetes on coronary heart disease risk.
33 Jääskeläinen P et al. Genetics of hypertrophic cardiomyopathy in eastern Finland: few founder mutations with benign or intermediary phenotypes.
34 Klareskog L et al. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.
35 Korpela M et al. Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: five-year experience from the FIN-RACo study.
36 Koukkunen H et al. Low-risk patients with chest pain and without evidence of myocardial infarction may be safely discharged from emergency department.
37 Krishnan E et al. Normative values for the health assessment questionnaire disability index: benchmarking disability in the general population.
38 Kubaszek A. Plasma Cell Glycoprotein-1, Interleukin-6 and Tumor Necrosis Factor-Alfa as Candidate Genes for Insulin Resistance, Obesity and Type 2 Diabetes .
39 Kubaszek A et al. The association of the K121Q polymorphism of the plasma cell glycoprotein-1 gene with type 2 diabetes and hypertension depends on size at birth.
40 Kuittinen T et al. Prediction of mobilisation failure in patients with non-Hodgkin's lymphoma.
41 Kärkkäinen S. Genetics of Dilated Cardiomyopathy in the Eastern Finnish Population .
42 Kärkkäinen S et al. Two novel mutations in the beta-myosin heavy chain gene associated with dilated cardiomyopathy.
43 Kärkkäinen S et al. A novel mutation, Ser143Pro, in the lamin A/C gene is common in finnish patients with familial dilated cardiomyopathy.
44 Laakso M. The relative importance of cardiovascular risk factors in type 2 diabetic.
45 Laakso M. Gene variants, insulin resistance, and dyslipidaemia.
46 Laaksonen DE et al. Serum linoleic and total polyunsaturated fatty acids in relation to prostate and other cancers: a populationbased cohort study.
47 Laaksonen DE et al. Epidemiology and treatment of the metabolic syndrome.
48 Laaksonen DE et al. C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men.
49 Laaksonen DE et al. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men.
50 Laitinen T et al. Age dependency of cardiovascular autonomic responses to head-up tilt in healthy subjects.
51 Laivoranta-Nyman S et al. HLA-DR-DQ haplotypes and genotypes in Finnish patients with rheumatoid arthritis.
52 Laukkanen JA et al. Metabolic syndrome and the risk of prostate cancer in Finnish men: a population-based study.
53 Laukkanen O et al. Common polymorphisms in the genes regulating the early insulin signalling pathway: effects on weight change and the conversion from impaired glucose tolerance to Type 2 diabetes.
54 Laukkanen O et al. Polymorphisms of the SUR1 (ABCC8) and Kir6.2 (KCNJ11) genes predict the conversion from impaired glucose tolerance to type 2 diabetes. The Finnish diabetes prevention study.
55 Mähönen MS et al. Current smoking and the risk of non-fatal myocardial infarction in the WHO MONICA project populations.
56 Mäkinen H et al. Ortopedistä leikkausta odottavien nivelreumapotilaiden jononpurkuprojekti Keski-Suomen keskussairaalassa.
57 Niklason A et al. Development of diabetes is retarded by ACE inhibition in hypertensive patients--a subanalysis of the Captopril Prevention Project (CAPPP).
58 Niskanen L. Oraaliset diabeteslääkkeet - missä mennään?
59 Niskanen L et al. Randomized, multinational, open-label, 2-period, crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispro 25 and pen devices in adult patients with type 2 diabetes mellitus .
60 Niskanen L et al. Inflammation, abdominal obesity, and smoking as predictors of hypertension.
61 Niskanen L et al. Changes in sex hormone-binding globulin and testosterone during weight loss and weight maintenance in abdominally obese men with the metabolic syndrome.
62 Niskanen LK et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort .
63 Pajukanta P et al. Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1).
64 Penttinen M et al. Fabryn tauti ja suositus sen diagnostiikasta, seurannasta ja hoitolinjoista Suomessa.
65 Pihlajamäki J et al. Insulin resistance is associated with increased cholesterol synthesis and decreased cholesterol absorption in normoglycemic men.
66 Pihlajamäki J et al. The Pro12Ala polymorphism of the PPARgamma2 gene regulates weight from birth to adulthood.
67 Pirinen E et al. Analysis of the human hexokinase II promoter in vivo: lack of insulin response within 4.0 kb.
68 Puolakka K et al. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: A five-year randomized followup trial.
69 Pyörälä K et al. Risk factor management in diabetic and non-diabetic patients with coronary heart disease. Findings from the EUROASPIRE I and II surveys.
70 Pöyhönen M et al. The effect of carbon dioxide, respiratory rate and tidal volume on human heart rate variability.
71 Rioux JD et al. Genomewide search and association studies in a Finnish celiac disease population: identification of a novel locus and replication of HLA and CTLA4 loci.
72 Ristikankare M et al. Is routine sedation or topical pharyngeal anesthesia beneficial during upper endoscopy?
73 Rutanen J et al. The Val103Ile polymorphism of melanocortin-4 receptor regulates energy expenditure and weight gain.
74 Rutanen J et al. Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart.
75 Ruutu T et al. Oral treatment of acute myeloid leukaemia with etoposide, thioguanine, and idarubicin (ETI) in elderly patients: a prospective randomised comparison with intravenous cytarabine, idarubicin, and thioguanine in the second and third treatment cycle.
76 Salmenniemi U et al. Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome.
77 Salopuro T et al. Common variants in beta2- and beta3-adrenergic receptor genes and uncoupling protein 1 as predictors of the risk for type 2 diabetes and body weight changes. The Finnish diabetes prevention study .
78 Siitonen N et al. Association between a deletion/insertion polymorphism in the alfa2B-adrenergic receptor gene and insulin secretion and type 2 diabetes. The Finnish diabetes prevention study.
79 Sivenius K. Genetic Studies on Type 2 Diabetes Mellitus with Special Emphasis on Obesity and Microvascular Complications.
80 Sivenius K et al. Aldose reductase gene polymorphisms and susceptibility to microvascular complications in type 2 diabetes.
81 Sivenius K et al. Aldose reductase gene polymorphisms and peripheral nerve function in patients with type 2 diabetes.
82 Soinio M et al. Elevated plasma homocysteine level is an independent predictor of coronary heart disease events in patients with type 2 diabetes mellitus.
83 Sokka T, Hannonen P. Reply [to Erosions rare without clinically detectable inflammation].
84 Sokka T et al. Similar prediction of mortality by the health assessment questionnaire in patients with rheumatoid arthritis and the general population.
85 Suomen Kardiologisen Seuran asettama työryhmä. Syvä laskimotukos ja keuhkoembolia.
86 Suomen Sisätautilääkärien Yhdistys ry:n asettama työryhmä. Dyslipidemiat.
87 Tahvanainen K et al. Cellular phone use does not acutely affect blood pressure or heart rate of humans.
88 Tapola NS et al. Mineral water fortified with folic acid, vitamins B6, B12, D and calcium improves folate status and decreases plasma homocysteine concentration in men and women.
89 Temelkova-Kurktschiev T et al. Ala12Ala genotype of the peroxisome proliferator-activated receptor gamma2 protects against atherosclerosis.
90 The DREAM Trial Investigators. Rationale, design and recruitment characteristics of a large, simple international trial of diabetes prevention: the DREAM trial.
91 The FIELD Study Investigators. The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabets (FIELD) study. [ISRCTN64783481].
92 Todorova B et al. The G-250A promoter polymorphism of the hepatic lipase gene predicts the conversion from impaired glucose tolerance to type 2 diabetes mellitus: the Finnish Diabetes Prevention Study.
93 Uusimaa P et al. Plasma B-type natriuretic peptide reflects left ventricular hypertrophy and diastolic function in hypertension.
94 Valkeinen H et al. Changes in knee extension and flexion force, EMG and functional capacity during strength training in older females with fibromyalgia and healthy controls.
95 Vehviläinen A et al. Työikäisten sepelvaltimotautipotilaiden hoidon kokonaiskustannukset.
96 Vornanen M et al. Maha-suolikanavan lymfoomat.
97 Wilding J et al. A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects.
98 Yliharsila H et al. Interactions between peroxisome proliferator-activated receptor-gamma 2 gene polymorphisms and size at birth on blood pressure and the use of antihypertensive medication.

Sisätautien yksikkö Department of Internal Medicine
Julkaisutietokanta 15.4.2008 Publications Data Base 15.4.2008